21:15 IST
NSE
Earnings Call
Syngene International Investor Presentation: Key Takeaways
Syngene reports Q1 FY27 revenue of Rs 736 Cr (-16% YoY). Performance was impacted by low offtake from a major client and forex losses.
Syngene International Ltd
- Share price
- ₹378.70
- Market cap
- ₹15,287 Cr
- Revenue (annual)
- ₹3,739 Cr
- Net profit (annual)
- ₹316.7 Cr
- P/E (TTM)
- 69.2×Sector 50.4×
- Promoter holding
- 52.59%-0.09% QoQ
- FII holding
- 11.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
21:35 IST
NSE
Earnings Call
Syngene International Earnings Call: Key Takeaways
Syngene FY26 results show muted 3% revenue growth due to 'Librela' destocking headwinds. Management indicates FY27 will be a transition year with flat revenue and mid-20s EBITDA margins.
17:20 IST
NSE
Earnings Call
Syngene International Earnings Call: Key Takeaways
Syngene faces a transition year in FY27 as the Librela de-stocking headwind masks underlying momentum in biologics and research services.
13:21 IST
BSE
Earnings Call
Syngene International Earnings Call: Key Takeaways
Syngene Q4 FY26 revenue grew 2% YoY to Rs 1,037 Cr with 29% EBITDA margin. Full year FY26 revenue reached Rs 3,739 Cr, driven by integrated CRDMO services.
13:15 IST
NSE
Earnings Call
Syngene International Earnings Call: Key Takeaways
Syngene reported Q4 FY26 revenue of ₹1,037 Cr (up 2% YoY) and FY26 revenue of ₹3,739 Cr (up 3% YoY). Management announced leadership transitions including a new CEO effective July 2026.